Matches in SemOpenAlex for { <https://semopenalex.org/work/W2739784889> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2739784889 abstract "Triple-negative breast cancer (TNBC) has a poor prognosis and new drugs are urgently needed. The CYP-derived ω-3 epoxyeicosapentaenoic acid and its saturated analogues were found to activate apoptosis in MDA-MB-231 TNBC cells [1] , [2] , but in vivo instability limits their drug potential. We prepared stable bioisosteres of ω-3 epoxy-fatty acids for testing in TNBC cells in vitro and in vivo. Cell viability was assessed by ATP formation, cell killing by caspase-3/7 activity and annexin V/7AAD staining, mitochondrial membrane potential with JC-1, gene profiling by RNA-seq and real-time RT-PCR, and protein expression by immunoblotting. In vivo tumour growth was evaluated in nude mice carrying intramammary xenografts. Of 11 bioisosteres, one agent – CTU – impaired ATP formation, activated apoptosis and disrupted the mitochondrion in TNBC cells. RNA-seq profiling identified 382 differentially-expressed genes (⩾2-fold) in CTU-treated cells with selective enrichment of genes for endoplasmic reticulum (ER) stress (XBP-1 and CHOP). The ER-stress inhibitors, AEBSF and toyocamycin, attenuated caspase-3/7 activation by CTU. MDA-MB-231 xenografts in nude mice were decreased to 42 ± 13% of control after CTU (40 mg/kg i.p., 7 weeks). Increased TUNEL and Ki-67 staining in tumours is consistent with CTU-mediated apoptosis and decreased proliferation in vivo. CTU acts by a unique mechanism to target the mitochondrion and activate ER-stress, and is the prototype of a new class of agents based on naturally occurring lipids with activity in TNBC." @default.
- W2739784889 created "2017-08-08" @default.
- W2739784889 creator A5003022695 @default.
- W2739784889 creator A5003967548 @default.
- W2739784889 creator A5015114813 @default.
- W2739784889 creator A5024297030 @default.
- W2739784889 creator A5071406648 @default.
- W2739784889 creator A5071497406 @default.
- W2739784889 creator A5089190235 @default.
- W2739784889 date "2017-09-01" @default.
- W2739784889 modified "2023-09-27" @default.
- W2739784889 title "O25 A novel synthetic ω-3 fatty acid epoxide analogue activates breast cancer cell killing in vitro and in vivo" @default.
- W2739784889 cites W1878301782 @default.
- W2739784889 cites W2321436395 @default.
- W2739784889 doi "https://doi.org/10.1016/j.bcp.2017.06.090" @default.
- W2739784889 hasPublicationYear "2017" @default.
- W2739784889 type Work @default.
- W2739784889 sameAs 2739784889 @default.
- W2739784889 citedByCount "0" @default.
- W2739784889 crossrefType "journal-article" @default.
- W2739784889 hasAuthorship W2739784889A5003022695 @default.
- W2739784889 hasAuthorship W2739784889A5003967548 @default.
- W2739784889 hasAuthorship W2739784889A5015114813 @default.
- W2739784889 hasAuthorship W2739784889A5024297030 @default.
- W2739784889 hasAuthorship W2739784889A5071406648 @default.
- W2739784889 hasAuthorship W2739784889A5071497406 @default.
- W2739784889 hasAuthorship W2739784889A5089190235 @default.
- W2739784889 hasConcept C150903083 @default.
- W2739784889 hasConcept C153911025 @default.
- W2739784889 hasConcept C185592680 @default.
- W2739784889 hasConcept C190283241 @default.
- W2739784889 hasConcept C207001950 @default.
- W2739784889 hasConcept C502942594 @default.
- W2739784889 hasConcept C55493867 @default.
- W2739784889 hasConcept C86803240 @default.
- W2739784889 hasConcept C88634738 @default.
- W2739784889 hasConceptScore W2739784889C150903083 @default.
- W2739784889 hasConceptScore W2739784889C153911025 @default.
- W2739784889 hasConceptScore W2739784889C185592680 @default.
- W2739784889 hasConceptScore W2739784889C190283241 @default.
- W2739784889 hasConceptScore W2739784889C207001950 @default.
- W2739784889 hasConceptScore W2739784889C502942594 @default.
- W2739784889 hasConceptScore W2739784889C55493867 @default.
- W2739784889 hasConceptScore W2739784889C86803240 @default.
- W2739784889 hasConceptScore W2739784889C88634738 @default.
- W2739784889 hasLocation W27397848891 @default.
- W2739784889 hasOpenAccess W2739784889 @default.
- W2739784889 hasPrimaryLocation W27397848891 @default.
- W2739784889 hasRelatedWork W1758131448 @default.
- W2739784889 hasRelatedWork W1999341523 @default.
- W2739784889 hasRelatedWork W2039827667 @default.
- W2739784889 hasRelatedWork W2100297011 @default.
- W2739784889 hasRelatedWork W2122760343 @default.
- W2739784889 hasRelatedWork W2158942521 @default.
- W2739784889 hasRelatedWork W2520959410 @default.
- W2739784889 hasRelatedWork W2576848049 @default.
- W2739784889 hasRelatedWork W2597354017 @default.
- W2739784889 hasRelatedWork W2606027880 @default.
- W2739784889 hasRelatedWork W2606941815 @default.
- W2739784889 hasRelatedWork W2617444563 @default.
- W2739784889 hasRelatedWork W2745520252 @default.
- W2739784889 hasRelatedWork W2895872706 @default.
- W2739784889 hasRelatedWork W2924545244 @default.
- W2739784889 hasRelatedWork W2978091223 @default.
- W2739784889 hasRelatedWork W3005264451 @default.
- W2739784889 hasRelatedWork W3039929782 @default.
- W2739784889 hasRelatedWork W3129346088 @default.
- W2739784889 hasRelatedWork W3139394554 @default.
- W2739784889 isParatext "false" @default.
- W2739784889 isRetracted "false" @default.
- W2739784889 magId "2739784889" @default.
- W2739784889 workType "article" @default.